A Sugar Land-based pharmaceutical company plans to expand after being granted a $1.3 million incentive from its home city.

Preview this article 1 min The planned expansion led by a multi-national joint venture will nearly double the complex’s size ...

Perth biotech Syngenis Labs has banked an oversubscribed $4M pre-IPO raise to expand its AI-powered RNA platform and ...

Targeted reshoring is economically challenging given thin product margins; tariffs alone may not make US manufacturing ...

Researchers at Lawrence Livermore National Laboratory (LLNL) have modernized high-explosive (HE) manufacturing by adapting ...

New York invests $65M in biotech with new clinical trial consortium and Biogenesis Park to compete with Boston, San Francisco ...

The FDA PreCheck Pilot Program will focus on manufacturing readiness, regulatory predictability, and expedited facility ...

This week in Houston real estate news, a multifamily development in Friendswood, a new property management hire at Partners ...

The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined ...

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has begun cell line development ...

BioProcess International reviews key biotech trends from the first half of 2026, including US onshoring, China's biologics ...

FUJIFILM Biotechnologies (Fujifilm), a world-leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today announced that its ...